IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer’s Research
–News Direct– By Faith Ashmore, Benzinga As of 2023, the estimated number of Americans living with Alzheimers disease was 6.7 million. However, a lesser-known subsection of Alzheimers is Agitation in dementia from Alzheimers Disease (AAD). Recent research suggests that up to 76% of individuals with Alzheimer's also suffer from AAD. AAD is known to contribute…